PURPOSE: The purpose of the study is to analyze the results obtained using stents for the treatment of neurovascular diseases in pediatric patients. METHODS: A retrospective study of 6-year period was undertaken evaluating clinical charts and imaging studies of patients treated with stents because of neurovascular diseases. RESULTS: Nine patients were managed with 10 stents. Seven children were females. The median age was 11 years. There were four cases of broad neck cerebral aneurysms, a pseudoaneurysm of the cervical internal carotid artery, a vertebro-jugular fistula, two patients with internal carotid artery (ICA) stenosis affecting the cervical and supraclinoid segment, and a vertebral artery dissection. The only complication was a silent posterior communicating artery (PCoA) thrombosis in a PCoA aneurysm treated with two stents. Dual antiplatelet therapy was given after the procedure to avoid in stent thrombosis. CONCLUSION: Stents are safe and effective for treatment of neurovascular diseases in children, but studies are needed in order to protocolize the use of antiplatelet drugs in children.
PURPOSE: The purpose of the study is to analyze the results obtained using stents for the treatment of neurovascular diseases in pediatric patients. METHODS: A retrospective study of 6-year period was undertaken evaluating clinical charts and imaging studies of patients treated with stents because of neurovascular diseases. RESULTS: Nine patients were managed with 10 stents. Seven children were females. The median age was 11 years. There were four cases of broad neck cerebral aneurysms, a pseudoaneurysm of the cervical internal carotid artery, a vertebro-jugular fistula, two patients with internal carotid artery (ICA) stenosis affecting the cervical and supraclinoid segment, and a vertebral artery dissection. The only complication was a silent posterior communicating artery (PCoA) thrombosis in a PCoA aneurysm treated with two stents. Dual antiplatelet therapy was given after the procedure to avoid in stent thrombosis. CONCLUSION: Stents are safe and effective for treatment of neurovascular diseases in children, but studies are needed in order to protocolize the use of antiplatelet drugs in children.
Authors: Therese M Giglia; M Patricia Massicotte; James S Tweddell; Robyn J Barst; Mary Bauman; Christopher C Erickson; Timothy F Feltes; Elyse Foster; Kathleen Hinoki; Rebecca N Ichord; Jacqueline Kreutzer; Brian W McCrindle; Jane W Newburger; Sarah Tabbutt; Jane L Todd; Catherine L Webb Journal: Circulation Date: 2013-11-13 Impact factor: 29.690
Authors: Karam Moon; Felipe C Albuquerque; Andrew F Ducruet; R Webster Crowley; Cameron G McDougall Journal: J Neurointerv Surg Date: 2014-04-28 Impact factor: 5.836
Authors: N Chalouhi; R M Starke; M T Koltz; P M Jabbour; S I Tjoumakaris; A S Dumont; R H Rosenwasser; S Singhal; L F Gonzalez Journal: AJNR Am J Neuroradiol Date: 2013-05-02 Impact factor: 3.825